Patrick De Baetselier

Active 1980–2024

88
Papers
18,112
Citations
80
h-index
88
i10-index

Citations

Citations per year for Patrick De Baetselier1981: 1 citations1982: 1 citations1983: 1 citations1984: 5 citations1985: 8 citations1986: 2 citations1987: 5 citations1988: 4 citations1989: 3 citations1990: 3 citations1991: 5 citations1992: 5 citations1993: 10 citations1994: 11 citations1995: 11 citations1996: 20 citations1997: 25 citations1998: 49 citations1999: 59 citations2000: 55 citations2001: 81 citations2002: 72 citations2003: 65 citations2004: 129 citations2005: 122 citations2006: 119 citations2007: 127 citations2008: 165 citations2009: 182 citations2010: 259 citations2011: 284 citations2012: 274 citations2013: 267 citations2014: 283 citations2015: 237 citations2016: 265 citations2017: 258 citations2018: 259 citations2019: 583 citations2020: 678 citations2021: 713 citations2022: 532 citations2023: 334 citations2024: 458 citations2025: 228 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,079 citing papers, 24.8% of this breakdownChina: 1,048 citing papers, 12.5% of this breakdownUnited Kingdom: 547 citing papers, 6.5% of this breakdownGermany: 530 citing papers, 6.3% of this breakdownBelgium: 498 citing papers, 5.9% of this breakdownFrance: 387 citing papers, 4.6% of this breakdownItaly: 326 citing papers, 3.9% of this breakdownNetherlands: 286 citing papers, 3.4% of this breakdownJapan: 211 citing papers, 2.5% of this breakdownAustralia: 195 citing papers, 2.3% of this breakdownCanada: 188 citing papers, 2.3% of this breakdownSwitzerland: 166 citing papers, 2% of this breakdown
0%24.8%Other 23%

Fields

  • Immunology and Microbiology44.6%
  • Medicine34.9%
  • Biochemistry, Genetics and Molecular Biology13.3%
  • Neuroscience2.4%
  • Engineering1.4%
  • Agricultural and Biological Sciences0.9%
  • Other2.5%

Topics

  • Immune cells in cancer12.6%
  • Immune Cell Function and Interaction5.7%
  • Immunotherapy and Immune Responses5%
  • Immune Response and Inflammation3.5%
  • Cancer Immunotherapy and Biomarkers3.1%
  • Monoclonal and Polyclonal Antibodies Research2.9%
  • Other67.2%

Coauthors

All papers

Open in search
  1. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

    Authors: , , , , , , , , , , , , , - Nature Communications 2016 cited by 850

  2. Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes

    Authors: , , , , , , , , , , - Cancer Research 2010 cited by 1,212

  3. The Transcription Factor ZEB2 Is Required to Maintain the Tissue-Specific Identities of Macrophages

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2018 cited by 284

  4. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity

    Authors: , , , , , , , - Blood 2008 cited by 1,220

  5. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 608

  6. The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2016 cited by 269

  7. Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population

    Authors: , , , , , , , , , , , , , , , , - Cancer Research 2013 cited by 402

  8. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment

    Authors: , , , , , , , , , , , , , , - Cancer Research 2015 cited by 233

  9. Camelid immunoglobulins and nanobody technology

    Authors: , , , , , , , , , , , , , , , , - Veterinary Immunology and Immunopathology 2008 cited by 539

  10. Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs

    Authors: , , , , - Blood 2011 cited by 181

  11. Pivotal Advance: Arginase-1-independent polyamine production stimulates the expression of IL-4-induced alternatively activated macrophage markers while inhibiting LPS-induced expression of inflammatory genes

    Authors: , , , , , , , , , , , , - Journal of Leukocyte Biology 2012 cited by 140

  12. Apolipoprotein L-I is the trypanosome lytic factor of human serum

    Authors: , , , , , , , , , , , , , , , - Nature 2003 cited by 495

  13. Efficient Cancer Therapy with a Nanobody-Based Conjugate

    Authors: , , , , , , - Cancer Research 2004 cited by 372

  14. Arginase-1 and Ym1 Are Markers for Murine, but Not Human, Alternatively Activated Myeloid Cells

    Authors: , , , - The Journal of Immunology 2005 cited by 300

  15. Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages

    Authors: , , , , , , , , , , , - Cancer Research 2012 cited by 286

  16. Nanobodies as novel agents for cancer therapy

    Authors: , , - Expert Opinion on Biological Therapy 2005 cited by 256

  17. Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression

    Authors: , , , , - Frontiers in Immunology 2014 cited by 201

  18. Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT

    Authors: , , , , , , , , , - Journal of Nuclear Medicine 2008 cited by 218

  19. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions

    Authors: , , , , , , , , , - The International Journal of Developmental Biology 2011 cited by 306

  20. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages

    Authors: , , , , , - Journal of Leukocyte Biology 2002 cited by 439

  21. Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion

    Authors: , , , , , , - Immunobiology 2006 cited by 368

  22. Efficient tumor targeting by single‐domain antibody fragments of camels

    Authors: , , , , , , , - International Journal of Cancer 2002 cited by 255

  23. SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression

    Authors: , , , , , , , , - Molecular Imaging and Biology 2008 cited by 188

  24. PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments

    Authors: , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2015 cited by 157